Affordable HPV Vaccination
On June 29, 2006, the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) unanimously recommended Merck's new Human Papillomavirus vaccine, GARDASIL®, for girls and women 11 to 26 years old. The Committee also approved the vaccine for 9- and 10-year-old girls at the discretion of their physicians.
The GARDASIL vaccine is the only vaccine available in the United States for the prevention of HPV types 16- and 18- related cervical cancer. GARDASIL is to be administered in three separate doses over a six-month period. Each dose of GARDASIL currently sells for $120, putting a price tag of $360 on the full HPV vaccination. Merck has, however, been working hard to try to distribute the vaccine to those who cannot afford it, both within the U.S. and abroad.